| Literature DB >> 21238927 |
Tanya P Zand1, David J Reiner, Channing J Der.
Abstract
The C. elegans vulva is patterned by epidermal growth factor (EGF) activation of Ras to control 1° fate, and 1° fate induces antagonistic Notch-dependent 2° fate. Furthermore, a spatial EGF gradient, in addition to inducing 1° fate, directly contributes to 2° fate via an unknown pathway. We find that in addition to its canonical effector, Raf, vulval Ras utilizes an exchange factor for the Ral small GTPase (RalGEF), such that Ras-RalGEF-Ral antagonizes Ras-Raf pro-1° fate activity. Consistent with its restricted expression pattern, Ral participates in EGF pro-2° activity. Thus, we have delineated a Ras effector-switching mechanism whereby position within the morphogen gradient dictates that Ras effector usage is switched to RalGEF from Raf to promote 2° instead of 1° fate. Our observations define the utility of Ras effector switching during normal development and may provide a possible mechanistic basis for cell and cancer-type differences in effector dependency and activation. Copyright ÂEntities:
Mesh:
Substances:
Year: 2011 PMID: 21238927 PMCID: PMC3028984 DOI: 10.1016/j.devcel.2010.12.004
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270